USP8 and renal cell carcinoma: To the best of our knowledge, this is the first work to elucidate that abundantly expressed piR-1742 might act as a critical mediator in the activation of USP8/MUC12 signaling, hence enhancing the proliferation of RCC cells while also promoting RCC invasion and metastasis.